Molecular Partners • MOLN
Molecular Partners AG is a clinical stage biopharmaceutical company.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Patrick Amstutz, PhD$121.6M
Market Cap • 19/04/20242004
(há 20 anos)
2021
(3 years ago)
NASDAQ
Listagem
Zurich
175
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MOLNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.